Nod for Ranbaxy Malaysia plan
By ENS Economic Bureau - NEW DELHI
14th September 2012 10:15 AM
Ranbaxy Malaysia Sdn Bhd, a wholly- owned subsidiary of Ranbaxy Labs, has got the Malaysian government’s approval for setting up a greenfield manufacturing plant in there.
Ranbaxy will be investing around RM 125 million ($40 Million) in this project and will be Ranbaxy’s second facility in Malaysia.
“The setting up of a new facility reinforces our commitment to the Malaysian market. In addition to serving the local market the facility will also export products to markets like ASEAN, West Asia, Europe, Lanka, China,” said Arun Sawhney, CEO & MD, Ranbaxy.
The new plant would manufacture dosage forms primarily in the cardiovascular, anti diabetic, anti-infective and gastrointestinal segments. Its total output in Malaysia will be increased from 1 billion doses per annum to 3 billion doses per year when the new plant becomes fully operational.
- You are aiming high, but beware of marketers selling you as an FMCG
- With Advani visit, Modi begins charm offensive
- Social media goes martial over High Court's marital ruling
- Slum removal scheme tweaked to make it more effective
- Ready to tune in the lord, catch him up on Twitter
- 95 per cent stolen goods not recovered in Kerala, says NCRB
- Karnataka MLAs were frugal in their poll spending
- Now talcum powder linked to ovarian cancer
- Indian Coast Guards help rescue 26 crew from shipwreck near Yemen
- Thousands missing near Kedarnath shrine
- Army Major captures 'UFO' in Kerala
- Learnt to embrace simplicity from SRK: Puvisha
- Callgate: Doctors were prime target for Biju, Saritha Nair
- Prices of 348 drugs to come down drastically from May 15
- Flaws in Koodankulam plant
- Congress to vote in Nitish government's favour today